NIH-funded research R01 grant

Cefazolin Inoculum Effect in MSSA Bacteremia

Official title: Clinical Impact of the Cefazolin Inoculum Effect

Funded at Methodist Hospital Research Institute · NIH-11404809 · Data updated 2026-11-12

This project tests how cefazolin works in severe MSSA bloodstream infections and whether a rapid test can predict which patients might have worse outcomes.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionMethodist Hospital Research Institute
NIH-funded
Lab location1 site (Houston, United States)
Project startJune 5, 2023
Project endMay 31, 2028
Funding year2026
Award (this year)$425,805
NIH project number5R01AI173138-04
Project IDNIH-11404809 on NIH RePORTER

Who could benefit from this research

Could help

Adults and children with MSSA bacteremia, treated in participating hospitals, who could benefit from optimized antibiotic therapy based on CzIE detection.

Less likely to help

Patients without MSSA bacteremia or those not receiving cefazolin as part of their therapy may not benefit.

What this research studies

MSSA bacteremia is a serious infection and cefazolin is increasingly used as first-line therapy. The study develops a quick nitrocefin-based test to detect the cefazolin inoculum effect, with the goal of guiding which patients may need adjusted therapy. Researchers plan to compare patient outcomes with and without rapid CzIE detection to see if this approach improves safety and effectiveness. The work involves international collaboration and real-world clinical microbiology settings to translate the test into routine use.

Why it matters

Potential benefit: If successful, patients with MSSA bacteremia could receive more tailored and safer antibiotic choices, potentially improving survival and reducing side effects.

How similar studies have gone: Previous studies support Cefazolin as effective for MSSA infections and suggest CzIE may influence outcomes, but rapid clinical implementation remains unproven.

Where this research is happening

  • Methodist Hospital Research Institute
    Houston, United States
    Active

Researchers

  • Principal investigator: Arias, Cesar Augusto — Methodist Hospital Research Institute
  • Study coordinator: Arias, Cesar Augusto

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.